A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory.

ANNALS OF SURGICAL ONCOLOGY(2017)

Cited 15|Views107
No score
Abstract
Expanded cancer gene sequencing identifies more actionable genomic alterations. The option of CLIA validating research results can provide alternative targets for personalized cancer therapy.
More
Translated text
Key words
CLIA,clinical trial,genomics,precision medicine,somatic mutation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined